MedTrace Logo

Addressing Hypertension Care in Africa

NCT04010344 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2025-01-17

No results posted yet for this study

Summary

A pilot cluster randomized control trial to test the feasibility of a multilevel, nurse-led, mobile health enhanced intervention in patients with uncontrolled hypertension in Ghana

Conditions

Interventions

BEHAVIORAL

Enhanced Usual Care Group

Medtronic® Labs' Akoma pa app, a culturally-tested and locally attuned mobile health platform, will be used in the intervention arm of the study to improve communication between the Community Health Officer (CHO) and the participant. This platform will be used to enhance shared decision making, clinical decision support, participatory communication, knowledge, treatment adherence (medication and lifestyle modification), and self-monitoring of hypertension. We will test the feasibility of the Akoma pa app in addressing patient-level and provider-level barriers to hypertension control. The app will consist of the following components: 1. Reminders 2. Participant to CHO messaging 3. Home BP tracking 4. Educational materials on cardiovascular disease (CVD) and Stroke- Participants will have access to education modules on reducing the risk of CVD and stroke tailored to their knowledge level. 5. CHO provider portal- The provider portal will include decision support tools.

OTHER

Usual Care Group

Regular/usual appointments or visits to patients' healthcare provider for management of study outcomes

Sponsors & Collaborators

Principal Investigators

  • Yvonne Commodore-Mensah, PhD, MHS, RN · Johns Hopkins University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-14
Primary Completion
2021-05-03
Completion
2024-12-30

Countries

  • Ghana

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04010344 on ClinicalTrials.gov